34th Symposium on Pharmaceutical and Biomedical Analysis (PBA 2024)

The symposium will provide an international forum for high-level scientific exchange between young and advanced researchers from both industry and academia. The event will cover all aspects of pharmaceutical and biomedical analysis, including new analytical technologies and methods for (bio)pharmaceuticals, biomarkers, and “omics”.

Selected Speakers

  • Coral Barbas, Universidad San Pablo CEU, Spain
    Information Quality: The Analytical Chemistry Challenge in Metabolomics
  • Hugo Duminil-Copin, Université de Genève, Switzerland
    Can one truly understand by counting?
  • Gert Desmet, Vrije Universiteit Brussel, Belgium
    Performance Characteristics and Applications of Next-Generation Micro-Pillar Array Columns
  • Michal Holcapek, University of Pardubice, Czech Republic
    Translating UHPSFC/MS method into real clinical practice: Pancreatic cancer screening based on plasma lipidome
  • Valérie Pichon, Sorbonne University, France
    Bio- and bio-mimetic molecules as powerful tools for target analysis of compounds in biological fluids and complex molecule characterization
  • Koen Sandra, RIC, Belgium
    A journey into pharmaceutical and biomedical analysis: from metabolite biomarker discovery to characterization of protein and nucleic acid based medicines
  • Tim Causon, University of Natural Resources and Life Sciences, Austria
    Old and new directions for small molecule (bio-) analytical applications with ion mobility-mass spectrometry
  • Marianne Fillet, University of Liège, Belgium
    Characterization of extracellular vesicles, challenges, opportunities and prospects in therapeutics
  • Sandra Furlanetto, University of Florence, Italy
    Analytical Quality by Design and Quality control: from small molecules to biopharmaceuticals
  • Ana Garcia-Campaña, University of Granada, Spain
    Exploring Emerging Contaminants: Analytical Strategies in food safety and the Exposome Connection
  • Kenji Hamase, Graduate School of Pharmaceutical Sciences, Japan
    Multi-dimensional chiral HPLC analysis of amino acids and related compounds for drug discovery and diagnosis
  • Zhengjin Jiang, Jinan University, China
    From linear peptides to supramolecular mimotope peptide nanofibers: novel technologies for fast, efficient and high-throughput bioseparation of antibody drugs
  • Jingwu Kang, State Key Laboratory of Life Organic Chemistry, China
    Mass spectrometry-based multi-omics analysis for molecular pharmacology
  • Michal Markuszewski, Medical University of Gdansk, Poland
    Metabolomics in gastrointestinal stromal tumor studies
  • Gabriella Massolini, Pavia University, Italy
    Hydrophilic interaction liquid chromatography (HILIC) for intact proteins analysis: a journey into new glycoconjugated vaccines
  • Sibel Ozkan, European Chemical Society, Turkey
    Molecularly Imprinted Polymers (MIPs) in Sensors for pharmaceutical and biomedical assay- New Sensing Technologies
  • Myriam Taverna, University of Paris-Saclay, France
    Capillary electrophoresis-based strategies to characterize or predict in-vivo behaviour of nanomedicines
  • Jean-Luc Wolfender, The Phytochemistry Bioactive Natural Product Group (PBNP), Switzerland
    Confident MS-based Metabolite Annotation in Natural Product Metabolomics : New opportunities in the digital age
  • Nicola Zamboni, ETH Zurich, Switzerland
    Untargeted metabolomics in routine analysis
Event Details

Leave a Reply

Kindly review our community guidelines before leaving a comment.

Your email address will not be published. Required fields are marked *